China's first "B-brain live vaccine" will be pre-certified by WHO

July 10, the national high-tech industrialization demonstration project B-brain detoxification vaccine project started in Chengdu, the project by the Chengdu Institute of Biological Products, the investment of 180 million yuan, is expected to be completed in one yearDuring this period, the U.SHealth Science and Technology Organization will provide technical support to help the project pass the World Health Organization's pre-certificationB-brain live vaccine is by the ChineseDrugBiological Products Inspection Institute and Chengdu Institute of Biological Products jointly developed a successful biological products, is the international first, from 1998 in the domestic market, about 200 millionchildrenuse, the vaccine is safe and effective, small side reaction, less injections, cheap, was identified by the World Health Organization as the direction of development of the Bencephalitis vaccine development, and Chengdu production procedures for the development of the brain vaccine recommendedWu Yonglin, director of Chengdu Institute of Biological Products, told reporters that from the date of the birth of the b-brain vaccine, they have made efforts to bring the bio-vaccine to the international marketUp to now, the hivi vaccine is the first vaccine with independent intellectual property rights to obtain the registration of foreign government and large-scale export in ChinaIn 2006, Chengdu and the United States suitable technology and technology organizations signed a cooperation agreement, in accordance with the requirements of the agreement, the United States appropriate HEALTH organization to Chengdu technical support, to provide in line with the C
GMPrequirements of advice and training, to help the project through the World Health Organization pre-certification, that is, in 2008, Chengdu Institute of Biological Products will become the first domestic certified vaccine manufacturers, which will enhance China's biological products industry in the international market status, to provide a demonstration role for the domestic industry